PK/PD and Long Term Safety Study of Benralizumab in Children With Severe Eosinophilic Asthma

Clinical trial NCT04305405 · COMPLETED

Trial details

NCT number: NCT04305405
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Severe Uncontrolled Asthma

Start date: 2019-11-21
Primary completion: 2022-09-12
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.